Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Neurochemical Transmission: Sites of Drug Action

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>De Novo</i> Design of Peptide Masks Enables Rapid Generation of Conditionally-Active Miniprotein Binders.

Journal of the American Chemical Society·2025

Same author

Structure-Affinity Relationship Analysis and Affinity Maturation of a Calprotectin-Binding Peptide.

Chembiochem : a European journal of chemical biology·2025

Same author

BrainBike peptidomimetic enables efficient transport of proteins across brain endothelium.

RSC chemical biology·2024

Same author

Site-specific antibody masking enables conditional activation with different stimuli.

New biotechnology·2023

Same author

Encoding Noncanonical Amino Acids into Phage Displayed Proteins.

Methods in molecular biology (Clifton, N.J.)·2023

Same author

High-affinity peptides developed against calprotectin and their application as synthetic ligands in diagnostic assays.

Nature communications·2023

Search research articles

Related Experiment Video

Updated: Jun 9, 2026

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

Chemically enhanced brain shuttle peptides.

Cristina Díaz-Perlas¹

¹Department of Bioengineering, Institut Químic de Sarrià (IQS), Universitat Ramon Llull, Barcelona, Spain.

Advances in Pharmacology (San Diego, Calif.)

|June 7, 2026

Summary

Brain shuttle peptides are engineered to overcome the blood-brain barrier (BBB) for central nervous system (CNS) drug delivery. Optimization strategies enhance their ability to cross the BBB, paving the way for new CNS therapeutics.

Keywords:

Blood-brain barrier (BBB)Brain shuttle peptides Central nervous system (CNS)Cyclic peptides Multivalency Receptor-mediated transcytosis (RMT)Retro-enantio peptides Targeted CNS drug delivery

More Related Videos

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

Related Experiment Videos

Last Updated: Jun 9, 2026

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

An Improved Protocol to Purify and Directly Mono-Biotinylate Recombinant BDNF in a Tube for Cellular Trafficking Studies in Neurons

Published on: July 11, 2020

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Mouse Microsurgery Infusion Technique for Targeted Substance Delivery into the CNS via the Internal Carotid Artery

Published on: January 31, 2017

Area of Science:

Neuroscience
Pharmacology
Biotechnology

Background:

The blood-brain barrier (BBB) restricts drug entry into the central nervous system (CNS).
Brain shuttle peptides offer a promising strategy to enhance CNS drug delivery via receptor-mediated transcytosis.
Existing peptides face challenges with pharmacokinetic properties and efficiency.

Purpose of the Study:

To review and highlight advancements in brain shuttle peptide design for improved BBB penetration.
To discuss various optimization strategies for enhancing peptide transcytosis and drug delivery into the CNS.
To explore the potential of these engineered peptides for clinical translation in CNS pharmacotherapy.

Main Methods:

Review of structural modifications like cyclization and retro-enantio designs for proteolytic resistance.
Analysis of naturally occurring venom-derived peptide scaffolds for BBB penetration.
Evaluation of multivalent presentation and dual-ligand systems to improve avidity and cellular uptake.
Discussion of PEGylation's limited application due to potential interference with receptor-mediated uptake.

Main Results:

Engineered peptides (e.g., retro-D-THR, retro-D-T7, BB4) demonstrate proteolytic resistance and receptor affinity.
Venom-derived peptides (e.g., MiniAp-4, MiniCTX3) show potential for BBB penetration.
Multivalent and dual-ligand strategies significantly enhance transcytosis and targeting (e.g., THR-TAT conjugates in glioma models).

Conclusions:

Protease-resistant brain shuttle peptides are versatile for targeted CNS drug delivery.
Optimization strategies have significantly improved BBB crossing efficiency.
These advances provide a strong foundation for the clinical application of brain shuttle peptides in treating CNS disorders.